Syra Health Corp.
SYRA
$0.0502
-$0.005-9.06%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.98M | 7.74M | 7.07M | 6.08M | 5.52M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.98M | 7.74M | 7.07M | 6.08M | 5.52M |
| Cost of Revenue | 6.33M | 5.96M | 5.40M | 4.64M | 4.11M |
| Gross Profit | 1.65M | 1.78M | 1.67M | 1.44M | 1.41M |
| SG&A Expenses | 4.77M | 5.13M | 4.98M | 4.43M | 4.01M |
| Depreciation & Amortization | 62.70K | 67.80K | 54.70K | 49.60K | 48.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.75M | 11.99M | 11.23M | 9.64M | 8.40M |
| Operating Income | -3.77M | -4.25M | -4.16M | -3.56M | -2.89M |
| Income Before Tax | -3.76M | -4.25M | -4.19M | -3.60M | -2.94M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.76 | -4.25 | -4.19 | -3.60 | -2.94 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.76M | -4.25M | -4.19M | -3.60M | -2.94M |
| EBIT | -3.77M | -4.25M | -4.16M | -3.56M | -2.89M |
| EBITDA | -3.70M | -4.18M | -4.11M | -3.51M | -2.84M |
| EPS Basic | -0.54 | -0.65 | -0.67 | -0.64 | -0.60 |
| Normalized Basic EPS | -0.34 | -0.40 | -0.42 | -0.40 | -0.38 |
| EPS Diluted | -0.54 | -0.65 | -0.67 | -0.64 | -0.60 |
| Normalized Diluted EPS | -0.34 | -0.40 | -0.42 | -0.40 | -0.38 |
| Average Basic Shares Outstanding | 30.20M | 26.73M | 23.83M | 21.61M | 19.46M |
| Average Diluted Shares Outstanding | 30.20M | 26.73M | 23.83M | 21.61M | 19.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |